BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12719702)

  • 21. Loss of 1p in recurrent meningiomas. a comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization.
    López-Ginés C; Cerdá-Nicolás M; Gil-Benso R; Barcia-Salorio JL; Llombart-Bosch A
    Cancer Genet Cytogenet; 2001 Mar; 125(2):119-24. PubMed ID: 11369054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.
    Maillo A; Orfao A; Sayagues JM; Diaz P; Gómez-Moreta JA; Caballero M; Santamarta D; Santos-Briz A; Morales F; Tabernero MD
    J Clin Oncol; 2003 Sep; 21(17):3285-95. PubMed ID: 12947064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
    Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
    Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel chromosomal aberrations in a recurrent malignant meningioma.
    Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monosomy 1p and alkaline phosphatase in meningiomas. Citopathological, histochemical and genetical study in 10 tumors].
    Cerdá-Nicolás M; López-Ginés C; Pérez-Bacete M; Talamantes F; Roldán P
    Med Clin (Barc); 2002 May; 118(17):656-8. PubMed ID: 12028903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: correlation with clinical, histopathologic, and prognostic features.
    Tabernero MD; Espinosa AB; Maíllo A; Sayagués JM; Alguero Mdel C; Lumbreras E; Díaz P; Gonçalves JM; Onzain I; Merino M; Morales F; Orfao A
    Am J Clin Pathol; 2005 May; 123(5):744-51. PubMed ID: 15981814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Meningiomas with disomy of chromosome 22: study of 9 cases].
    López-Ginés C; Cerdá-Nicolás M; Pérez-Bacete M; Barcia-Salorio JL; Llombart-Bosch A
    Med Clin (Barc); 1998 Nov; 111(17):663-6. PubMed ID: 9881350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1.
    Niedermayer I; Feiden W; Henn W; Steilen-Gimbel H; Steudel WI; Zang KD
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):879-86. PubMed ID: 9258258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
    Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Ketter R; Rahnenführer J; Henn W; Kim YJ; Feiden W; Steudel WI; Zang KD; Urbschat S
    Neurosurgery; 2008 Jan; 62(1):61-9; discussion 69-70. PubMed ID: 18300892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.
    Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O
    Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors.
    Zattara-Cannoni H; Gambarelli D; Dufour H; Figarella D; Vollot F; Grisoli F; Vagner-Capodano AM
    Ann Genet; 1998; 41(3):164-75. PubMed ID: 9833072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression.
    Murakami M; Hashimoto N; Takahashi Y; Hosokawa Y; Inazawa J; Mineura K
    Cancer Genet Cytogenet; 2003 Jan; 140(2):99-106. PubMed ID: 12645646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of genes on the long arm of chromosome 22 in human meningiomas.
    Okazaki M; Nishisho I; Tateishi H; Motomura K; Yamamoto M; Miki T; Hayakawa T; Takai S; Honjo T; Mori T
    Mol Biol Med; 1988 Feb; 5(1):15-22. PubMed ID: 2897611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
    Dumanski JP; Rouleau GA; Nordenskjöld M; Collins VP
    Cancer Res; 1990 Sep; 50(18):5863-7. PubMed ID: 2393856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.